The US Supreme Court’s decision striking down Purdue Pharma’s bankruptcy settlement is already being craftily applied by lawyers looking to push its authority as far as possible and carefully parsed by judges interpreting the extent of its impact.
The high court, in rejecting liability releases for members of the billionaire Sackler family who owned Purdue, found they were illegal because they were given without the consent of some people who sued the family over its opioid sales tactics.
The long-awaited ruling in Harrington v. Purdue Pharma was bound to shake up the bankruptcy world, which has relied on litigation shields ...